NOVONIX Ltd Files March 2025 6-K Report
Ticker: NVNXF · Form: 6-K · Filed: Apr 1, 2025 · CIK: 1859795
| Field | Detail |
|---|---|
| Company | Novonix Ltd (NVNXF) |
| Form Type | 6-K |
| Filed Date | Apr 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
NOVONIX filed its March 6-K, confirming 20-F reporting and including Appendix 2A.
AI Summary
NOVONIX Limited filed a Form 6-K on April 1, 2025, for the month of March 2025. The filing indicates that NOVONIX is a foreign private issuer and will file annual reports under Form 20-F. The report includes an Exhibit Index with Appendix 2A (Application) as Exhibit 99.1.
Why It Matters
This filing provides an update on NOVONIX's reporting status as a foreign private issuer and includes an appendix, which may contain operational or financial details relevant to investors.
Risk Assessment
Risk Level: low — This is a routine periodic filing (6-K) that primarily confirms reporting status and includes an appendix, with no immediate indication of significant new risks.
Key Players & Entities
- NOVONIX Limited (company) — Registrant
- 0000950170-25-047942 (filing_id) — Accession Number
- 20250331 (date) — Period of Report
- 20250401 (date) — Filed as of Date
- Form 6-K (document) — Filing Type
- Form 20-F (document) — Annual Report Form
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information as required by Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 for the month of March 2025, and to indicate that NOVONIX Limited files its annual reports under Form 20-F.
What is the filing date and reporting period for this document?
The filing was made on April 1, 2025, and it covers the reporting period for the month of March 2025, with the 'as of' date being March 31, 2025.
What is included in the Exhibit Index of this filing?
The Exhibit Index lists Exhibit 99.1, which is described as 'Appendix 2A (Application)'.
Is NOVONIX Limited submitting this Form 6-K in paper format?
The filing indicates by check marks that the registrant is not submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) or Rule 101(b)(7).
Where is NOVONIX Limited's principal executive office located?
NOVONIX Limited's principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 1, 2025 regarding NOVONIX Ltd (NVNXF).